Correlation Between Johnson Johnson and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Allovir, you can compare the effects of market volatilities on Johnson Johnson and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Allovir.

Diversification Opportunities for Johnson Johnson and Allovir

-0.85
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Johnson and Allovir is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Allovir go up and down completely randomly.

Pair Corralation between Johnson Johnson and Allovir

Considering the 90-day investment horizon Johnson Johnson is expected to generate 18.46 times less return on investment than Allovir. But when comparing it to its historical volatility, Johnson Johnson is 5.14 times less risky than Allovir. It trades about 0.05 of its potential returns per unit of risk. Allovir is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  626.00  in Allovir on July 1, 2022 and sell it today you would earn a total of  159.00  from holding Allovir or generate 25.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Johnson Johnson  vs.  Allovir

 Performance (%) 
       Timeline  
Johnson Johnson 
Johnson Performance
0 of 100
Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Johnson Price Channel

Allovir 
Allovir Performance
12 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Allovir are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Allovir reported solid returns over the last few months and may actually be approaching a breakup point.

Allovir Price Channel

Johnson Johnson and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Johnson Johnson and Allovir

The main advantage of trading using opposite Johnson Johnson and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
Johnson Johnson vs. Amazon Inc
The idea behind Johnson Johnson and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Allovir vs. Dentsu Inc
Allovir vs. PUBLICIS GROUPE SA
Allovir vs. Insignia Systems
Allovir vs. Wpp Plc Ord
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Shere Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go